Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://shaniabpjg349152.blogsuperapp.com/39557128/trelaglutide-exploring-a-new-therapy-for-chronic-diseases